{"entity":{"type":"insider","cik":"0001551778","url":"/insider/0001551778","json_url":"/insider/0001551778.json","name":"Malik Fady Ibraham","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":164,"n_filings":119,"first":"2014-12-31","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Malik Fady Ibraham","source":"filing","n_filings":119,"first_seen":"2014-12-31","last_seen":"2026-08-18"}],"transactions":[{"id":9218943,"accession":"0001061983-26-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000088","line_url":"/filing/0001061983-26-000088#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":75.82,"price_display":"75.82","price_state":"stated","total_value":265370.0,"total_display":"265,370.00","total_whole":"265,370","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-18","scope":"insider"},{"id":6105364,"accession":"0001061983-26-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000084","line_url":"/filing/0001061983-26-000084#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":80.59,"price_display":"80.59","price_state":"stated","total_value":282065.0,"total_display":"282,065.00","total_whole":"282,065","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":6218290,"accession":"0001061983-26-000075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000075","line_url":"/filing/0001061983-26-000075#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":86.62,"price_display":"86.62","price_state":"stated","total_value":303170.0,"total_display":"303,170.00","total_whole":"303,170","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-07","scope":"insider"},{"id":5739403,"accession":"0001061983-26-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000069","line_url":"/filing/0001061983-26-000069#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":79.51,"price_display":"79.51","price_state":"stated","total_value":278285.0,"total_display":"278,285.00","total_whole":"278,285","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-23","scope":"insider"},{"id":5855627,"accession":"0001061983-26-000067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000067","line_url":"/filing/0001061983-26-000067#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":67.98,"price_display":"67.98","price_state":"stated","total_value":237930.0,"total_display":"237,930.00","total_whole":"237,930","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-09","filed_date":"2026-06-09","scope":"insider"},{"id":6014064,"accession":"0001061983-26-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000053","line_url":"/filing/0001061983-26-000053#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":75.69,"price_display":"75.69","price_state":"stated","total_value":264915.0,"total_display":"264,915.00","total_whole":"264,915","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-20","scope":"insider"},{"id":6070646,"accession":"0001061983-26-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000051","line_url":"/filing/0001061983-26-000051#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":77.37,"price_display":"77.37","price_state":"stated","total_value":270795.0,"total_display":"270,795.00","total_whole":"270,795","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-05","filed_date":"2026-05-05","scope":"insider"},{"id":5833012,"accession":"0001061983-26-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000043","line_url":"/filing/0001061983-26-000043#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":65.69,"price_display":"65.69","price_state":"stated","total_value":229915.0,"total_display":"229,915.00","total_whole":"229,915","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-21","filed_date":"2026-04-21","scope":"insider"},{"id":5768684,"accession":"0001061983-26-000034","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-26-000034","line_url":"/filing/0001061983-26-000034","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":65.10777777777778,"price_display":"65.11","price_state":"stated","total_value":292985.0,"total_display":"292,985.00","total_whole":"292,985","shares_owned_after":153902.0,"shares_owned_after_display":"153,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-08","scope":"insider","n_lines":2},{"id":6081705,"accession":"0001061983-26-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-26-000027","line_url":"/filing/0001061983-26-000027","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12033.0,"shares_display":"12,033","price_per_share":62.15,"price_display":"62.15","price_state":"stated","total_value":747850.95,"total_display":"747,850.95","total_whole":"747,851","shares_owned_after":158299.0,"shares_owned_after_display":"158,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":5761419,"accession":"0001061983-26-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-26-000017","line_url":"/filing/0001061983-26-000017#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2907.0,"shares_display":"2,907","price_per_share":60.72,"price_display":"60.72","price_state":"stated","total_value":176513.04,"total_display":"176,513.04","total_whole":"176,513","shares_owned_after":138629.0,"shares_owned_after_display":"138,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-10","scope":"insider"},{"id":4102204,"accession":"0001061983-25-000050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000050","line_url":"/filing/0001061983-25-000050#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":61.24,"price_display":"61.24","price_state":"stated","total_value":134728.0,"total_display":"134,728.00","total_whole":"134,728","shares_owned_after":138552.0,"shares_owned_after_display":"138,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-16","scope":"insider"},{"id":5077144,"accession":"0001061983-25-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000041","line_url":"/filing/0001061983-25-000041#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":63.89,"price_display":"63.89","price_state":"stated","total_value":140558.0,"total_display":"140,558.00","total_whole":"140,558","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-02","scope":"insider"},{"id":4621503,"accession":"0001061983-25-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000037","line_url":"/filing/0001061983-25-000037#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":66.45,"price_display":"66.45","price_state":"stated","total_value":146190.0,"total_display":"146,190.00","total_whole":"146,190","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-18","scope":"insider"},{"id":5077126,"accession":"0001061983-25-000029","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000029","line_url":"/filing/0001061983-25-000029#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2295.0,"shares_display":"2,295","price_per_share":59.55,"price_display":"59.55","price_state":"stated","total_value":136667.25,"total_display":"136,667.25","total_whole":"136,667","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-04","scope":"insider"},{"id":4948892,"accession":"0001061983-25-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000025","line_url":"/filing/0001061983-25-000025#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2105.0,"shares_display":"2,105","price_per_share":58.22,"price_display":"58.22","price_state":"stated","total_value":122553.1,"total_display":"122,553.10","total_whole":"122,553","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-21","filed_date":"2025-10-21","scope":"insider"},{"id":4247046,"accession":"0001061983-25-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000009","line_url":"/filing/0001061983-25-000009#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":60.56,"price_display":"60.56","price_state":"stated","total_value":121120.0,"total_display":"121,120.00","total_whole":"121,120","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-07","scope":"insider"},{"id":4913893,"accession":"0001061983-25-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001061983-25-000005","line_url":"/filing/0001061983-25-000005#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":49.28,"price_display":"49.28","price_state":"stated","total_value":98560.0,"total_display":"98,560.00","total_whole":"98,560","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-23","filed_date":"2025-09-23","scope":"insider"},{"id":4371195,"accession":"0001127602-25-021253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-021253","line_url":"/filing/0001127602-25-021253#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":51.29,"price_display":"51.29","price_state":"stated","total_value":102580.0,"total_display":"102,580.00","total_whole":"102,580","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-10","scope":"insider"},{"id":4577096,"accession":"0001127602-25-020711","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-020711","line_url":"/filing/0001127602-25-020711#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":38.31,"price_display":"38.31","price_state":"stated","total_value":76620.0,"total_display":"76,620.00","total_whole":"76,620","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-08-19","scope":"insider"},{"id":4753659,"accession":"0001127602-25-020109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-020109","line_url":"/filing/0001127602-25-020109#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":36.34,"price_display":"36.34","price_state":"stated","total_value":72680.0,"total_display":"72,680.00","total_whole":"72,680","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-05","scope":"insider"},{"id":4350294,"accession":"0001127602-25-019506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-019506","line_url":"/filing/0001127602-25-019506#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":37.47,"price_display":"37.47","price_state":"stated","total_value":74940.0,"total_display":"74,940.00","total_whole":"74,940","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-22","filed_date":"2025-07-23","scope":"insider"},{"id":4878190,"accession":"0001127602-25-019021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-019021","line_url":"/filing/0001127602-25-019021#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":33.76,"price_display":"33.76","price_state":"stated","total_value":67520.0,"total_display":"67,520.00","total_whole":"67,520","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-08","filed_date":"2025-07-08","scope":"insider"},{"id":5165530,"accession":"0001127602-25-017640","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-017640","line_url":"/filing/0001127602-25-017640#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":32.91,"price_display":"32.91","price_state":"stated","total_value":65820.0,"total_display":"65,820.00","total_whole":"65,820","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-17","filed_date":"2025-06-17","scope":"insider"},{"id":4753384,"accession":"0001127602-25-016470","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-016470","line_url":"/filing/0001127602-25-016470#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":31.88,"price_display":"31.88","price_state":"stated","total_value":63760.0,"total_display":"63,760.00","total_whole":"63,760","shares_owned_after":140610.0,"shares_owned_after_display":"140,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-03","scope":"insider"},{"id":4170043,"accession":"0001127602-25-015023","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-015023","line_url":"/filing/0001127602-25-015023#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":31.98,"price_display":"31.98","price_state":"stated","total_value":63960.0,"total_display":"63,960.00","total_whole":"63,960","shares_owned_after":140255.0,"shares_owned_after_display":"140,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-20","scope":"insider"},{"id":4631939,"accession":"0001127602-25-013482","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-013482","line_url":"/filing/0001127602-25-013482#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":35.01,"price_display":"35.01","price_state":"stated","total_value":70020.0,"total_display":"70,020.00","total_whole":"70,020","shares_owned_after":140255.0,"shares_owned_after_display":"140,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-06","filed_date":"2025-05-06","scope":"insider"},{"id":5165086,"accession":"0001127602-25-012436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-012436","line_url":"/filing/0001127602-25-012436#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":38.11,"price_display":"38.11","price_state":"stated","total_value":76220.0,"total_display":"76,220.00","total_whole":"76,220","shares_owned_after":140255.0,"shares_owned_after_display":"140,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-22","scope":"insider"},{"id":4727373,"accession":"0001127602-25-011829","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-011829","line_url":"/filing/0001127602-25-011829#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":36.18,"price_display":"36.18","price_state":"stated","total_value":72360.0,"total_display":"72,360.00","total_whole":"72,360","shares_owned_after":140255.0,"shares_owned_after_display":"140,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-08","filed_date":"2025-04-08","scope":"insider"},{"id":4631709,"accession":"0001127602-25-009780","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-009780","line_url":"/filing/0001127602-25-009780#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":43.58,"price_display":"43.58","price_state":"stated","total_value":87160.0,"total_display":"87,160.00","total_whole":"87,160","shares_owned_after":140455.0,"shares_owned_after_display":"140,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-18","scope":"insider"},{"id":5131430,"accession":"0001127602-25-009711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-009711","line_url":"/filing/0001127602-25-009711#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4389.0,"shares_display":"4,389","price_per_share":44.38,"price_display":"44.38","price_state":"stated","total_value":194783.82,"total_display":"194,783.82","total_whole":"194,784","shares_owned_after":101005.0,"shares_owned_after_display":"101,005","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-17","scope":"insider"},{"id":5131400,"accession":"0001127602-25-008791","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-008791","line_url":"/filing/0001127602-25-008791#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8228.0,"shares_display":"8,228","price_per_share":43.27,"price_display":"43.27","price_state":"stated","total_value":356025.56,"total_display":"356,025.56","total_whole":"356,026","shares_owned_after":105394.0,"shares_owned_after_display":"105,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-06","filed_date":"2025-03-07","scope":"insider"},{"id":4595031,"accession":"0001127602-25-007915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-007915","line_url":"/filing/0001127602-25-007915#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":42.5,"price_display":"42.50","price_state":"stated","total_value":85000.0,"total_display":"85,000.00","total_whole":"85,000","shares_owned_after":116071.0,"shares_owned_after_display":"116,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4957498,"accession":"0001127602-25-008321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-008321","line_url":"/filing/0001127602-25-008321#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2449.0,"shares_display":"2,449","price_per_share":42.88,"price_display":"42.88","price_state":"stated","total_value":105013.12,"total_display":"105,013.12","total_whole":"105,013","shares_owned_after":113622.0,"shares_owned_after_display":"113,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4801422,"accession":"0001127602-25-005237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-005237","line_url":"/filing/0001127602-25-005237#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":45.98,"price_display":"45.98","price_state":"stated","total_value":91960.0,"total_display":"91,960.00","total_whole":"91,960","shares_owned_after":116071.0,"shares_owned_after_display":"116,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-18","scope":"insider"},{"id":5164033,"accession":"0001127602-25-002944","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-002944","line_url":"/filing/0001127602-25-002944#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":48.06,"price_display":"48.06","price_state":"stated","total_value":96120.0,"total_display":"96,120.00","total_whole":"96,120","shares_owned_after":116071.0,"shares_owned_after_display":"116,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":4852423,"accession":"0001127602-25-001636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-001636","line_url":"/filing/0001127602-25-001636#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":45.92,"price_display":"45.92","price_state":"stated","total_value":91840.0,"total_display":"91,840.00","total_whole":"91,840","shares_owned_after":116071.0,"shares_owned_after_display":"116,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-21","scope":"insider"},{"id":4956528,"accession":"0001127602-25-001059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-001059","line_url":"/filing/0001127602-25-001059#line-2","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":49.32,"price_display":"49.32","price_state":"stated","total_value":98640.0,"total_display":"98,640.00","total_whole":"98,640","shares_owned_after":116071.0,"shares_owned_after_display":"116,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider"},{"id":2627297,"accession":"0001127602-24-028977","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-028977","line_url":"/filing/0001127602-24-028977","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":50.635479452054796,"price_display":"50.64","price_state":"stated","total_value":369639.0,"total_display":"369,639.00","total_whole":"369,639","shares_owned_after":118071.0,"shares_owned_after_display":"118,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-10","scope":"insider","n_lines":2},{"id":2504476,"accession":"0001127602-24-028135","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-028135","line_url":"/filing/0001127602-24-028135","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":50.16178082191781,"price_display":"50.16","price_state":"stated","total_value":366181.0,"total_display":"366,181.00","total_whole":"366,181","shares_owned_after":113878.0,"shares_owned_after_display":"113,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-26","scope":"insider","n_lines":2},{"id":3123549,"accession":"0001127602-24-027240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-027240","line_url":"/filing/0001127602-24-027240","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6342.0,"shares_display":"6,342","price_per_share":58.48,"price_display":"58.48","price_state":"stated","total_value":370880.16,"total_display":"370,880.16","total_whole":"370,880","shares_owned_after":114920.0,"shares_owned_after_display":"114,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider","n_lines":2},{"id":3123279,"accession":"0001127602-24-026160","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-026160","line_url":"/filing/0001127602-24-026160","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":51.90821917808219,"price_display":"51.91","price_state":"stated","total_value":378930.0,"total_display":"378,930.00","total_whole":"378,930","shares_owned_after":116920.0,"shares_owned_after_display":"116,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-30","filed_date":"2024-10-31","scope":"insider","n_lines":2},{"id":3069073,"accession":"0001127602-24-025636","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-24-025636","line_url":"/filing/0001127602-24-025636","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001551778","owner_name":"Malik Fady Ibraham","owner_display_name":"Malik Fady Ibraham","owner_url":"/insider/0001551778","role":"Officer (EVP Research & Development)","role_mark":"O","role_mark_label":"Officer (EVP Research & Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Research & Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7300.0,"shares_display":"7,300","price_per_share":54.18547945205479,"price_display":"54.19","price_state":"stated","total_value":395554.0,"total_display":"395,554.00","total_whole":"395,554","shares_owned_after":118920.0,"shares_owned_after_display":"118,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2024-10-15|3069069","ledger_fault":false,"count":{"value":164,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":164,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":164},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Officer (EVP Research & Development)","n_filings":119,"first_seen":"2014-12-31","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551778","retrieved_at":"2026-08-27T06:51:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}